NCT02869035View on ClinicalTrials.gov

Treatment Outcome in Major Depressive Disorder

PHASE1CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

August 31, 2016

Primary Completion Date

July 31, 2019

Study Completion Date

July 31, 2019

Conditions
Major Depressive Disorder
Interventions
DRUG

Escitalopram

Patients will be treated with an antidepressant drug (escitalopram) at flexible standard doses for 12 weeks. If no response after 4 weeks; shift to duloxetine arm.

DRUG

Duloxetine

Patients who at 4 weeks of escitalopram have not responded will be shifted to duloxetine at flexible standard dosages.

Trial Locations (1)

2100

Neurobiology Research Unit, Rigshospitalet, Copenhagen

All Listed Sponsors
collaborator

Center for Integrated Molecular Brain Imaging, Copenhagen, Denmak

OTHER

collaborator

Psychiatric Centre Copenhagen

UNKNOWN

collaborator

Central Visitation, Region Hovedstaden

UNKNOWN

lead

Rigshospitalet, Denmark

OTHER

NCT02869035 - Treatment Outcome in Major Depressive Disorder | Biotech Hunter | Biotech Hunter